Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging (pelvic ultrasound or MRI) within in last 12 months
Age = 18 years and = 50 years
Pre-operative hemoglobin >8 g/dl
Willing to have buccal administration of misoprostol or a placebo at least one hour pre-procedure.
Ability to understand and the willingness to sign a written informed consent.
Admissible medical/surgical history
Can be previously treated with Depo-Lupron, Depo-Provera, or Oral Contraceptive pills
Intraoperative use of vasopressin and uterine tourniquet is permissible
Can have had prior Cesarean delivery

NCT02209545_inc_T1
Procedure
abdominal myomectomy
NCT02209545_inc_T2
Condition
uterine fibroids
NCT02209545_inc_T3
Procedure
pelvic imaging
NCT02209545_inc_T4
Procedure
pelvic ultrasound
NCT02209545_inc_T5
Procedure
MRI pelvic
NCT02209545_inc_T6
Scope
pelvic ultrasound or MRI
NCT02209545_inc_T7
Scope
pelvic imaging (pelvic ultrasound or MRI)
NCT02209545_inc_T8
Temporal
within in last 12 months
NCT02209545_inc_T9
Person
Age
NCT02209545_inc_T10
Value
= 18 years and = 50 years
NCT02209545_inc_T11
Temporal
Pre-operative
NCT02209545_inc_T12
Reference_point
operative
NCT02209545_inc_T13
Procedure
operative
NCT02209545_inc_T14
Measurement
hemoglobin
NCT02209545_inc_T15
Value
>8 g/dl
NCT02209545_inc_T16
Procedure
buccal administration
NCT02209545_inc_T17
Drug
misoprostol
NCT02209545_inc_T18
Qualifier
buccal administration
NCT02209545_inc_T19
Drug
placebo
NCT02209545_inc_T20
Temporal
at least one hour pre-procedure
NCT02209545_inc_T21
Mood
Willing to have
NCT02209545_inc_T22
Scope
misoprostol or a placebo
NCT02209545_inc_T25
Observation
ity to understand and itten informed consent.
Ad
NCT02209545_inc_T23
Observation
willingness to sign a written informed consent
NCT02209545_inc_T24
Observation
surgical history
NCT02209545_inc_T26
Observation
al/surg ry
Can
NCT02209545_inc_T27
Qualifier
Admissible
NCT02209545_inc_T28
Drug
Depo-Lupron
NCT02209545_inc_T29
Drug
Depo-Provera
NCT02209545_inc_T30
Drug
Oral Contraceptive pills
NCT02209545_inc_T31
Procedure
treated
NCT02209545_inc_T32
Temporal
previously
NCT02209545_inc_T33
Scope
Depo-Lupron, Depo-Provera, or Oral Contraceptive pills